Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Lupus Nephritis"" wg kryterium: Temat


Tytuł :
Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
Autorzy :
Kwon OC; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Park JH; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Lee SW; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Song JJ; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Park YB; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Park MC; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło :
Yonsei medical journal [Yonsei Med J] 2020 Nov; Vol. 61 (11), pp. 951-957.
Typ publikacji :
Journal Article
MeSH Terms :
Kidney/*physiopathology
Kidney Failure, Chronic/*etiology
Lupus Erythematosus, Systemic/*pathology
Lupus Nephritis/*pathology
Adult ; Biopsy ; Disease Progression ; Female ; Humans ; Lupus Erythematosus, Systemic/therapy ; Lupus Nephritis/complications ; Lupus Nephritis/therapy ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Severity of Illness Index ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
SLE-DAS: ready for routine use?
Autorzy :
Mathew A; Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
Chengappa KG; Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
Shah S; Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
Negi VS; Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India .
Pokaż więcej
Źródło :
Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Sep; Vol. 79 (9), pp. e116. Date of Electronic Publication: 2019 May 24.
Typ publikacji :
Letter; Comment
MeSH Terms :
Lupus Nephritis*
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid/analogs & derivatives ; Humans ; Longitudinal Studies
Opinia redakcyjna
Tytuł :
Response to: 'SLE-DAS: ready for routine use' by Mathew et al .
Autorzy :
Jesus D; Rheumatology Department, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal.; Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
Matos A; School of Technology and Management, Polytechnic Institute of Viseu, Viseu, Portugal.; Centre for the Study of Education, Technologies and Health, Viseu, Portugal.
Henriques C; School of Technology and Management, Polytechnic Institute of Viseu, Viseu, Portugal.; Centre for the Study of Education, Technologies and Health, Viseu, Portugal.; Centre for Mathematics, University of Coimbra, Coimbra, Portugal.
Zen M; Rheumatology Unit, Department of Rheumatology, University of Padova, Padova, Italy.
Doria A; Rheumatology Unit, Department of Rheumatology, University of Padova, Padova, Italy.
Inês LS; Rheumatology Department, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal .; Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
Pokaż więcej
Źródło :
Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Sep; Vol. 79 (9), pp. e117. Date of Electronic Publication: 2019 Jun 14.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Lupus Nephritis*
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid/analogs & derivatives ; Humans ; Longitudinal Studies
Czasopismo naukowe
Tytuł :
Comparison of treatment response and serious infection using tacrolimus, tacrolimus with mycophenolate mofetil, in comparison to cyclophosphamide as induction treatment for lupus nephritis.
Autorzy :
Song GG
Lee YH
Pokaż więcej
Źródło :
International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2020 Oct; Vol. 58 (10), pp. 550-556.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Infections*
Lupus Nephritis*
Bayes Theorem ; Cyclophosphamide ; Humans ; Immunosuppressive Agents ; Mycophenolic Acid ; Remission Induction ; Tacrolimus ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The role of hypoxia in the pathogenesis of lupus nephritis.
Autorzy :
Kurata Y; Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Tanaka T; Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Nangaku M; Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. Electronic address: .
Pokaż więcej
Źródło :
Kidney international [Kidney Int] 2020 Oct; Vol. 98 (4), pp. 821-823. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Kidney Diseases*
Lupus Nephritis*
Animals ; Hypoxia ; Mice ; T-Lymphocytes
Czasopismo naukowe
Tytuł :
Belimumab as Add-on Therapy in Lupus Nephritis.
Autorzy :
Ward M; From the Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD (M.W.); and the First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens (M.G.T.).
Tektonidou MG; From the Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD (M.W.); and the First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens (M.G.T.).
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Sep 17; Vol. 383 (12), pp. 1184-1185.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Lupus Nephritis*
Antibodies, Monoclonal, Humanized ; Humans ; Immunosuppressive Agents
Opinia redakcyjna
Tytuł :
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
Autorzy :
Furie R; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Rovin BH; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Houssiau F; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Malvar A; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Teng YKO; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Contreras G; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Amoura Z; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Yu X; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Mok CC; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Santiago MB; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Saxena A; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Green Y; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Ji B; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Kleoudis C; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Burriss SW; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Barnett C; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Roth DA; From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc - both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M.); the Department of Internal Medicine, Section of Nephrology, Leiden University Medical Center, Leiden, the Netherlands (Y.K.O.T.); the Division of Nephrology, Division of Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami (G.C.); Sorbonne Université, INSERM Unité 1135 (Z.A.), and Assistance Publique-Hôpitaux de Paris Sorbonne Université, Service de Médecine Interne 2, Institut Endocrinologie, Maladies Métaboliques et Médecine Interne, Centre de Référence National du Lupus et Syndrome des Antiphospholipides, Hôpital Pitié-Salpêtrière (Z.A.) - both in Paris; the Department of Nephrology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou (X.Y.), and the Department of Medicine, Tuen Mun Hospital, Hong Kong (C.C.M.) - both in China; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil (M.B.S.); the Division of Rheumatology, New York University School of Medicine, New York (A.S.); GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom (Y.G., B.J.); Parexel, Durham, NC (C.K.); and GlaxoSmithKline, Collegeville, PA (S.W.B., C.B., D.A.R.).
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Sep 17; Vol. 383 (12), pp. 1117-1128.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Lupus Nephritis/*drug therapy
Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; Azathioprine/therapeutic use ; Creatinine/urine ; Cyclophosphamide/therapeutic use ; Double-Blind Method ; Drug Therapy, Combination ; Enzyme Inhibitors/therapeutic use ; Female ; Glomerular Filtration Rate ; Humans ; Immunosuppressive Agents/adverse effects ; Infusions, Intravenous ; Intention to Treat Analysis ; Lupus Nephritis/mortality ; Male ; Mycophenolic Acid/therapeutic use ; Remission Induction
Czasopismo naukowe
Tytuł :
The Plight of Patients with Lupus Nephritis during the Outbreak of COVID-19 in Wuhan, China.
Autorzy :
Chen C; Department of Nephrology, Renmin Hospital of Wuhan University.
Yao B; Department of Nephrology, Renmin Hospital of Wuhan University.
Yan M; Department of Nephrology, Renmin Hospital of Wuhan University.
Su KE; Department of Nephrology, Renmin Hospital of Wuhan University.
Wang H; Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China.
Xu C; Department of Rheumatology, Allergy, and Immunology, Tan Tock Seng Hospital, Singapore. .
Pokaż więcej
Źródło :
The Journal of rheumatology [J Rheumatol] 2020 Sep 01; Vol. 47 (9), pp. 1452. Date of Electronic Publication: 2020 May 08.
Typ publikacji :
Letter; Comment
MeSH Terms :
Coronavirus*
Coronavirus Infections*
Lupus Nephritis*
Pandemics*
Pneumonia, Viral*
Betacoronavirus ; Centers for Disease Control and Prevention, U.S. ; China ; Humans ; United States
SCR Disease Name :
COVID-19
Opinia redakcyjna
Tytuł :
Outcome of patients with lupus nephritis under long-term immunonephrological care
Autorzy :
Polner K; Taraba István Művese Állomás,Szent Margit Kórház, Budapest.
Arányi J; II. Belgyógyászat, Nephrológia és Gasztroenterológia Osztály,Szent Margit Kórház, Budapest.
Braunitzer H; II. Belgyógyászat, Nephrológia és Gasztroenterológia Osztály,Szent Margit Kórház, Budapest.
Kaszás I; Patológia Osztály,Szent Margit Kórház, Budapest.
Haris Á; I. Belgyógyászat, Nephrológia és Gasztroenterológia Osztály,Péterfy Kórház-Rendelőintézet és Manninger Jenő Országos Traumatológiai Intézet, Budapest, Péterfy S. u. 8-20., 1076.
Pokaż więcej
Transliterated Title :
Tartós immunonephrológiai gondozásban részesült lupus nephritises betegeink hosszú távú kezelési eredményei
Źródło :
Orvosi hetilap [Orv Hetil] 2020 Aug; Vol. 161 (31), pp. 1293-1301.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Immunosuppressive Agents/*therapeutic use
Lupus Erythematosus, Systemic/*complications
Lupus Nephritis/*drug therapy
Adult ; Aged ; Female ; Humans ; Immunosuppressive Agents/administration & dosage ; Long-Term Care ; Lupus Nephritis/immunology ; Lupus Nephritis/psychology ; Male ; Middle Aged ; Quality of Life ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Update on Lupus Nephritis: Core Curriculum 2020.
Autorzy :
Parikh SV; The Ohio State University Wexner Medical Center, Columbus, OH.
Almaani S; The Ohio State University Wexner Medical Center, Columbus, OH.
Brodsky S; The Ohio State University Wexner Medical Center, Columbus, OH.
Rovin BH; The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: .
Pokaż więcej
Źródło :
American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2020 Aug; Vol. 76 (2), pp. 265-281. Date of Electronic Publication: 2020 Mar 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Kidney Transplantation*
Lupus Nephritis*/drug therapy
Lupus Nephritis*/epidemiology
Lupus Nephritis*/pathology
Lupus Nephritis*/physiopathology
Renal Dialysis*
Adrenal Cortex Hormones/*therapeutic use
Immunologic Factors/*therapeutic use
Kidney Failure, Chronic/*therapy
Adaptive Immunity/immunology ; Age Distribution ; Autoantibodies/immunology ; Autoimmunity/immunology ; Biopsy ; Cyclophosphamide/therapeutic use ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Immunity, Innate/immunology ; Immunosuppressive Agents/therapeutic use ; Induction Chemotherapy ; Kidney Failure, Chronic/etiology ; Maintenance Chemotherapy ; Male ; Mycophenolic Acid/therapeutic use ; Pregnancy ; Pregnancy Complications ; Urinalysis
Czasopismo naukowe
Tytuł :
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Autorzy :
Fanouriakis A; Rheumatology and Clinical Immunology Unit, 'Attikon' University Hospital, Athens, Greece.; Department of Rheumatology, 'Asklepieion' General Hospital, Athens, Greece.
Kostopoulou M; Department of Nephrology, 'G. Gennimatas' General Hospital, Athens, Greece.
Cheema K; Department of Medicine, Cambridge University, Cambridge, UK.
Anders HJ; Division of Nephrology, Department of Medicine IV, University Hospital LMU Munich, Munich, Germany.
Aringer M; Division of Rheumatology, Department of Medicine III, University Medical Center & Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany.
Bajema I; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Boletis J; Nephrology Department and Renal Transplantation Unit, 'Laikon' Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
Frangou E; Department of Nephrology, Limassol General Hospital, Limassol, Cyprus.
Houssiau FA; Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
Hollis J; Lupus nurse specialist, Addenbrooke's Hospital, Cambridge, UK.
Karras A; Department of Nephrology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Marchiori F; Lupus Europe, Rome, Italy.
Marks SD; University College London Great Ormond Street Institute of Child Health, NIHR Great Ormond Street Hospital Biomedical Research Centre, London, UK.
Moroni G; Nephrology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Mosca M; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Parodis I; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Praga M; Nephrology Department, Research Institute Hospital Universitario 12 de Octubre (i+12), Department of Medicine, Complutense University of Madrid, Madrid, Spain.
Schneider M; Department of Rheumatology & Hiller Research Unit Rheumatology, UKD, Heinrich-Heine University, Duesseldorf, Germany.
Smolen JS; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.
Tesar V; Department of Nephrology, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Trachana M; Pediatric Immunology and Rheumatology Referral Center, First Pediatric Clinic, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
van Vollenhoven RF; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Voskuyl AE; Rheumatology and Immunology Center, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Teng YKO; Centre of expertise for Lupus-, Vasculitis- and Complement-mediated Systemic autoimmune diseases, Department of Internal Medicine - section Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
van Leew B; Lupus Europe, Essex, UK.
Bertsias G; Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece.
Jayne D; Department of Medicine, Cambridge University, Cambridge, UK.
Boumpas DT; Rheumatology and Clinical Immunology Unit, 'Attikon' University Hospital, Athens, Greece .; Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Pokaż więcej
Źródło :
Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Jun; Vol. 79 (6), pp. 713-723. Date of Electronic Publication: 2020 Mar 27.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms :
Societies, Medical*
Immunosuppressive Agents/*therapeutic use
Lupus Nephritis/*drug therapy
Antirheumatic Agents/therapeutic use ; Azathioprine/therapeutic use ; Calcineurin Inhibitors/therapeutic use ; Drug Therapy, Combination ; Europe ; Glomerular Filtration Rate ; Glucocorticoids/therapeutic use ; Humans ; Hydroxychloroquine/therapeutic use ; Kidney Failure, Chronic/etiology ; Kidney Failure, Chronic/therapy ; Lupus Nephritis/complications ; Lupus Nephritis/pathology ; Lupus Nephritis/physiopathology ; Mycophenolic Acid/therapeutic use ; Proteinuria/etiology ; Proteinuria/therapy
Czasopismo naukowe
Tytuł :
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: a case report.
Autorzy :
Vassia V; Department of Translational Medicine, DiMet, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy.
Croce A; Department of Translational Medicine, DiMet, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy.
Ravanini P; Laboratory of Molecular Virology, AOU Maggiore della Carità, Novara, Italy.
Leutner M; Histopathology Unit, AOU Maggiore della Carità, Novara, Italy.
Saglietti C; Histopathology Unit, AOU Maggiore della Carità, Novara, Italy.
Fangazio S; Department of Translational Medicine, DiMet, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy.
Quaglia M; Department of Translational Medicine, DiMet, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy.
Smirne C; Department of Translational Medicine, DiMet, Università del Piemonte Orientale, via Solaroli 17, 28100, Novara, Italy. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Jul 23; Vol. 20 (1), pp. 538. Date of Electronic Publication: 2020 Jul 23.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antiphospholipid Syndrome/*complications
Antiphospholipid Syndrome/*diagnosis
Herpes Zoster/*complications
Herpes Zoster/*diagnosis
Herpesvirus 3, Human/*genetics
Lupus Nephritis/*complications
Lupus Nephritis/*diagnosis
Abdominal Pain ; Fatal Outcome ; Female ; Herpes Zoster/pathology ; Herpes Zoster/virology ; Herpesvirus 3, Human/isolation & purification ; Humans ; Immunocompromised Host ; Lupus Nephritis/drug therapy ; Middle Aged ; Mycophenolic Acid/therapeutic use ; Real-Time Polymerase Chain Reaction ; Steroids/therapeutic use
Czasopismo naukowe
Tytuł :
miR-133 inhibits proliferation and promotes apoptosis by targeting LASP1 in lupus nephritis.
Autorzy :
Huang Z; Department of Pediatric, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province 524001, China.
Pang G; VIP Inpatient Area, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, 524001, China. Electronic address: .
Huang YG; Department of Pediatric, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province 524001, China.
Li C; Department of Pediatric, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province 524001, China.
Pokaż więcej
Źródło :
Experimental and molecular pathology [Exp Mol Pathol] 2020 Jun; Vol. 114, pp. 104384. Date of Electronic Publication: 2020 Jan 24.
Typ publikacji :
Journal Article
MeSH Terms :
Adaptor Proteins, Signal Transducing/*genetics
Cell Proliferation/*genetics
Cytoskeletal Proteins/*genetics
LIM Domain Proteins/*genetics
Lupus Nephritis/*genetics
MicroRNAs/*genetics
Adolescent ; Adult ; Apoptosis/genetics ; Cell Movement/genetics ; Female ; Gene Expression Regulation/genetics ; Humans ; Lupus Nephritis/pathology ; Male ; Young Adult
Czasopismo naukowe
Tytuł :
Expression of inflammasomes NLRP1, NLRP3 and AIM2 in different pathologic classification of lupus nephritis.
Autorzy :
Huang T; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yin H; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ning W; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wang X; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Chen C; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Lin W; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Li J; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhou Y; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Peng Y; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wang M; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ni X; National International Joint Research Center for Medical Metabolomics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhang W; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. .
Pokaż więcej
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2020 Jul-Aug; Vol. 38 (4), pp. 680-690. Date of Electronic Publication: 2019 Oct 30.
Typ publikacji :
Journal Article
MeSH Terms :
Inflammasomes*
Lupus Nephritis*
Adaptor Proteins, Signal Transducing ; Apoptosis Regulatory Proteins ; DNA-Binding Proteins ; Humans ; Kidney ; Kidney Glomerulus ; NLR Family, Pyrin Domain-Containing 3 Protein
Czasopismo naukowe
Tytuł :
[Expression and diagnostic value of plasma miR-145 and miR-183 in children with lupus nephritis].
Autorzy :
Lin LJ; Department of Pediatrics, People's Hospital of Danzhou, Danzhou, Hainan 571799, China. .
Mai LJ
Chen G
Zhao EN
Xue M
Su XD
Pokaż więcej
Źródło :
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics [Zhongguo Dang Dai Er Ke Za Zhi] 2020 Jun; Vol. 22 (6), pp. 632-637.
Typ publikacji :
Journal Article
MeSH Terms :
Lupus Nephritis*/genetics
MicroRNAs/*genetics
Biomarkers ; Child ; Complement C4 ; Humans ; ROC Curve
Czasopismo naukowe
Tytuł :
Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.
Autorzy :
Yap DYH; Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong.
Tam CH; Nephrology Division, Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong.
Yung S; Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong.
Wong S; Nephrology Division, Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong.
Tang CSO; Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong.
Mok TMY; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Hong Kong, Hong Kong.; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong.
Yuen CKY; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Hong Kong, Hong Kong.
Ma MKM; Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong.
Lau CS; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Hong Kong, Hong Kong.
Chan TM; Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong.
Pokaż więcej
Źródło :
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2020 May 01; Vol. 35 (5), pp. 810-818.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Pharmacogenetics*
Polymorphism, Single Nucleotide*
Immunosuppressive Agents/*pharmacokinetics
Lupus Nephritis/*drug therapy
Multidrug Resistance-Associated Proteins/*genetics
Mycophenolic Acid/*pharmacokinetics
Organic Anion Transporters/*genetics
Adult ; Female ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/blood ; Lupus Nephritis/blood ; Lupus Nephritis/genetics ; Lupus Nephritis/pathology ; Male ; Mycophenolic Acid/administration & dosage ; Mycophenolic Acid/blood ; Prospective Studies ; Tissue Distribution
Czasopismo naukowe
Tytuł :
Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Autorzy :
Xiang L; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University of People's Liberation Army, Xi'an, China.
Liu A; Outpatient Department, Xi'an Children's Hospital, Xi'an, China.
Xu G; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University of People's Liberation Army, Xi'an, China.
Pokaż więcej
Źródło :
American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2020 May 01; Vol. 318 (5), pp. F1258-F1270. Date of Electronic Publication: 2020 Apr 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphocyte Activation*/drug effects
Terpenes*
B-Lymphocytes/*metabolism
Kidney/*metabolism
Lupus Erythematosus, Systemic/*metabolism
Lupus Nephritis/*metabolism
Spleen/*metabolism
X-Box Binding Protein 1/*metabolism
Animals ; Autoantibodies/blood ; B-Lymphocytes/drug effects ; B-Lymphocytes/pathology ; Cell Proliferation/drug effects ; Disease Models, Animal ; Female ; Immunoglobulin G/blood ; Kidney/drug effects ; Kidney/pathology ; Lupus Erythematosus, Systemic/chemically induced ; Lupus Erythematosus, Systemic/drug therapy ; Lupus Erythematosus, Systemic/pathology ; Lupus Nephritis/chemically induced ; Lupus Nephritis/drug therapy ; Lupus Nephritis/pathology ; Mice, Inbred BALB C ; Signal Transduction ; Spleen/drug effects ; Spleen/pathology ; Sulfonamides/pharmacology ; Thiophenes/pharmacology ; X-Box Binding Protein 1/antagonists & inhibitors ; X-Box Binding Protein 1/genetics
Czasopismo naukowe
Tytuł :
Transplant outcomes in kidney recipients with lupus nephritis, and systematic review.
Autorzy :
Kim JE; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kim YC; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Min SL; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Lee H; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Ha J; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Chin HJ; Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
Kim YS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Han SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło :
Lupus [Lupus] 2020 Mar; Vol. 29 (3), pp. 248-255. Date of Electronic Publication: 2020 Jan 29.
Typ publikacji :
Journal Article; Multicenter Study; Systematic Review
MeSH Terms :
Kidney Failure, Chronic/*surgery
Kidney Transplantation/*adverse effects
Kidney Transplantation/*mortality
Lupus Nephritis/*surgery
Adult ; Disease Progression ; Female ; Graft Rejection/epidemiology ; Graft Survival ; Humans ; Kidney Failure, Chronic/diagnosis ; Kidney Failure, Chronic/mortality ; Lupus Nephritis/diagnosis ; Lupus Nephritis/mortality ; Male ; Middle Aged ; Patient Safety ; Postoperative Complications/epidemiology ; Republic of Korea/epidemiology ; Retrospective Studies ; Survival Rate ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Naringenin mitigates autoimmune features in lupus-prone mice by modulation of T-cell subsets and cytokines profile.
Autorzy :
Abrego-Peredo A; Programa de Doctorado en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México.; Unidad de Citometría de Flujo, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Romero-Ramírez H; Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Ciudad de México, México.
Espinosa E; Investigación en Inmunología Integrativa, Instituto Nacional de Enfermedades Respiratorias, Ciudad de México, México.
López-Herrera G; Unidad de Investigación en Inmunodeficiencias, Instituto Nacional de Pediatría, Ciudad de México, México.
García-García F; Programa de Doctorado en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México.; Laboratorio de Biología del Sueño, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México.
Flores-Muñoz M; Programa de Doctorado en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México.; Laboratorio de Investigación en Medicina Traslacional, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México.
Sandoval-Montes C; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, México.
Rodríguez-Alba JC; Programa de Doctorado en Ciencias de la Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, México.; Unidad de Citometría de Flujo, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 May 18; Vol. 15 (5), pp. e0233138. Date of Electronic Publication: 2020 May 18 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cytokines/*immunology
Flavanones/*pharmacology
Immunologic Memory/*drug effects
Lupus Nephritis/*drug therapy
T-Lymphocytes, Regulatory/*immunology
Animals ; Disease Models, Animal ; Lupus Nephritis/immunology ; Lupus Nephritis/pathology ; Male ; Mice ; T-Lymphocytes, Regulatory/pathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies